{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:35:41Z","timestamp":1793226941059,"version":"4.5.0"},"reference-count":148,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Type 2 diabetes (T2D) and osteoporosis (OP) are major causes of morbidity and mortality that have arelevant health and economic burden. Recent epidemiological evidence suggests that both of these disorders are often associated with each other and that T2D patients have an increased risk of fracture, making bone an additional target of diabetes. As occurs for other diabetic complications, the increased accumulation of advanced glycation end-products (AGEs) and oxidative stress represent the major mechanisms explaining bone fragility in T2D. Both of these conditions directly and indirectly (through the promotion of microvascular complications) impair the structural ductility of bone and negatively affect bone turnover, leading to impaired bone quality, rather than decreased bone density. This makes diabetes-induced bone fragility remarkably different from other forms of OP and represents a major challenge for fracture risk stratification, since either the measurement of BMD or the use of common diagnostic algorithms for OP have a poor predictive value. We review and discuss the role of AGEs and oxidative stress on the pathophysiology of bone fragility in T2D, providing some indications on how to improve fracture risk prediction in T2D patients.<\/jats:p>","DOI":"10.3390\/antiox12040928","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T02:28:12Z","timestamp":1681439292000},"page":"928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification"],"prefix":"10.3390","volume":"12","author":[{"given":"Guido","family":"Cavati","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pirrotta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-6339","authenticated-orcid":false,"given":"Daniela","family":"Merlotti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Calabrese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gennari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mingiano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2017-00042","article-title":"Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management","volume":"102","author":"Paschou","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.numecd.2021.04.014","article-title":"Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel","volume":"22","author":"Chiodini","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_3","unstructured":"International Diabetes Federation (2021). IDF Diabetes Atlas, International Diabetes Federation. [10th ed.]. Available online: https:\/\/www.diabetesatlas.org."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and Macrovascular Complications of Diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: Now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"Klibanski","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","article-title":"Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus","volume":"17","author":"Khosla","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-018-0060-9","article-title":"Diabetes mellitus and bone health: Epidemiology, etiology and implications for fracture risk stratification","volume":"4","author":"Linares","year":"2018","journal-title":"Clin. Diab. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-015-3279-7","article-title":"Diabetes mellitus and risk of hip fractures: A meta-analysis","volume":"27","author":"Fan","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"IOF Bone and Diabetes Working Group. Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: Novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00198-019-05122-3","article-title":"The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: A multi-state cohort analysis","volume":"30","author":"Reyes","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc19-0925","article-title":"Vertebral fractures in individuals with type 2 diabetes: More than skeletal complications alone","volume":"43","author":"Koromani","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/ATVBAHA.117.307263","article-title":"ATVB Plenary Lecture: Receptor for advanced glycation endproducts and implications for the pathogenesis and treatment of cardiometabolic disorders: Spotlight on the macrophage","volume":"37","author":"Schmidt","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2015.07.028","article-title":"Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties","volume":"82","author":"Karim","year":"2016","journal-title":"Bone"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116485","DOI":"10.1016\/j.bone.2022.116485","article-title":"Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility","volume":"163","author":"Willett","year":"2022","journal-title":"Bone"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: A possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(98)00119-5","article-title":"Mechanisms of maturation and ageing of collagen","volume":"106","author":"Bailey","year":"1998","journal-title":"Mech. Ageing Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2006.12.056","article-title":"Effects of non-enzymatic glycation on cancellous bone fragility","volume":"40","author":"Tang","year":"2007","journal-title":"Bone"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00198-013-2319-4","article-title":"Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone","volume":"24","author":"Karim","year":"2013","journal-title":"Osteoporos. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116302","DOI":"10.1016\/j.bone.2021.116302","article-title":"Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach","volume":"156","author":"LLabre","year":"2022","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13813450701602523","article-title":"Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts","volume":"113","author":"Franke","year":"2007","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00223-012-9641-2","article-title":"Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis","volume":"91","author":"Okazaki","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/en.2013-1818","article-title":"Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-\u03b2 expression and secretion","volume":"155","author":"Notsu","year":"2014","journal-title":"Endocrinology"},{"key":"ref_29","first-page":"650","article-title":"Advanced glycation end products affect growth and function of osteoblasts","volume":"29","author":"Franke","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2015.02.091","article-title":"Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells","volume":"461","author":"Tanaka","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_31","first-page":"768","article-title":"RAGE and its ligands in bone metabolism","volume":"3","author":"Zhou","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20051947","article-title":"Regulation of osteoclast function and bone mass by RAGE","volume":"203","author":"Zhou","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1359\/jbmr.080234","article-title":"HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE","volume":"23","author":"Zhou","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2005.12.107","article-title":"Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss","volume":"340","author":"Ding","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1089\/scd.2016.0067","article-title":"Receptor for advanced glycation end products-mediated signaling impairs the maintenance of bone marrow mesenchymal stromal cells in diabetic model mice","volume":"25","author":"Aikawa","year":"2016","journal-title":"Stem Cells Dev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1152\/ajpendo.00564.2009","article-title":"RAGE supports parathyroid hormone-induced gains in femoral trabecular bone","volume":"298","author":"Philip","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2018.05.030","article-title":"Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes","volume":"114","author":"Karim","year":"2018","journal-title":"Bone"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1196\/annals.1333.082","article-title":"Advanced glycation end products and bone loss during aging","volume":"1043","author":"Odetti","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00774-007-0784-6","article-title":"Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures","volume":"26","author":"Shiraki","year":"2008","journal-title":"J. Bone Miner. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes","volume":"94","author":"Schwartz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jbmr.4466","article-title":"Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes","volume":"37","author":"Dhaliwal","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1210\/jc.2016-1437","article-title":"Advanced glycation endproducts and bone material strength in type 2 diabetes","volume":"101","author":"Furst","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1016\/S0021-9258(20)88225-8","article-title":"Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process","volume":"264","author":"Sell","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/jbmr.3552","article-title":"Phosphorylation of extracellular bone matrix proteins declines with age and contributes to bone fragility","volume":"33","author":"Sroga","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_46","first-page":"10548","article-title":"Controlled formation of carboxymethyllysine in bone matrix through designed glycation reaction","volume":"5","author":"Sroga","year":"2021","journal-title":"J. Bone Miner. Res. Plus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2018.01.028","article-title":"Accumulation of carboxymethyl-lysine (CML) in human cortical bone","volume":"110","author":"Thomas","year":"2018","journal-title":"Bone"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu. Rev. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","article-title":"High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells","volume":"49","author":"Inoguchi","year":"2000","journal-title":"Diabetes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbt.10058","article-title":"Diabetes, oxidative stress, and antioxidants: A review","volume":"17","author":"Maritim","year":"2003","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Marcucci, G., Domazetovic, V., Nediani, C., Ruzzolini, J., Favre, C., and Brandi, M.L. (2023). Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches. Antioxidants, 12.","DOI":"10.3390\/antiox12020373"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","article-title":"Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-\u03baB","volume":"30","author":"Bai","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/en.2004-1021","article-title":"Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation","volume":"146","author":"Lean","year":"2005","journal-title":"Endocrinology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1210\/er.2003-0036","article-title":"Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: Lessons from genetics and pharmacology","volume":"25","author":"Knouff","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","article-title":"Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPAR gamma 2","volume":"74","author":"Gubrij","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy- 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","article-title":"Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase","volume":"400","author":"Huang","year":"1999","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/endo.143.6.8834","article-title":"Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation","volume":"143","author":"Moerman","year":"2002","journal-title":"Endocrinology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/en.2004-1058","article-title":"Tumor necrosis factor mediates osteopenia caused by depletion of antioxidants","volume":"146","author":"Jagger","year":"2005","journal-title":"Endocrinology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/415045a","article-title":"p53 mutant mice that display early ageing-associated phenotypes","volume":"415","author":"Tyner","year":"2003","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1070174","article-title":"Premature aging in mice deficient in DNA repair and transcription","volume":"296","author":"Andressoo","year":"2002","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bone.2006.12.057","article-title":"Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: A possible role of oxidative stress","volume":"40","author":"Hamada","year":"2007","journal-title":"Bone"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bone.2007.10.007","article-title":"Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats","volume":"42","author":"Fujii","year":"2008","journal-title":"Bone"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00223-017-0327-7","article-title":"Does Oxidative Stress Play a Role in Altered Characteristics of Diabetic Bone? A Systematic Review","volume":"101","author":"Bacevic","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00296-007-0452-0","article-title":"Total oxidative\/anti-oxidative status and relation to bone mineral density in osteoporosis","volume":"28","author":"Altindag","year":"2008","journal-title":"Rheumatol. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.trsl.2007.03.012","article-title":"Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: A pilotstudy","volume":"150","author":"Sanders","year":"2007","journal-title":"Transl. Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Sanchez-Rodr\u00edguez, M.A., Ruiz-Ramos, M., Correa-Mu\u00f1oz, E., and Mendoza-N\u00f9\u00f1ez, V.M. (2007). Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet. Disord., 8.","DOI":"10.1186\/1471-2474-8-124"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/jbmr.2302","article-title":"Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: A prospective study","volume":"29","author":"Yang","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1210\/jc.2012-1546","article-title":"Circulating osteogenic precursor cells in type 2 diabetes mellitus","volume":"97","author":"Manavalan","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri.2016.63","article-title":"Innate sensing of oxidationspecific epitopes in health and disease","volume":"16","author":"Binder","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/ars.2005.7.256","article-title":"Lipid Peroxidation in Diabetes Mellitus","volume":"7","author":"Falco","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0891-5849(03)00185-0","article-title":"Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications","volume":"34","author":"Carrascosa","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1582-4934.2007.00068.x","article-title":"Changes in oxidant-antioxidant status in young diabetic patients from clinical onset onwards","volume":"11","author":"Carrascosa","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tem.2013.10.001","article-title":"Effects of bioactive lipids and lipoproteins on bone","volume":"25","author":"Tintut","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1152\/ajpendo.00501.2015","article-title":"Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice","volume":"1","author":"Liu","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1359\/jbmr.1999.14.12.2067","article-title":"Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells","volume":"14","author":"Parhami","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.freeradbiomed.2007.08.030","article-title":"Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells","volume":"44","author":"Brodeur","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.2008.01968.x","article-title":"Oxidation-specific epitopes are important targets of innate immunity","volume":"263","author":"Chou","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nri3515","article-title":"Scavenger receptors in homeostasis and immunity","volume":"13","author":"Canton","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e13442","DOI":"10.1111\/acel.13442","article-title":"Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice","volume":"20","author":"Palmieri","year":"2021","journal-title":"Aging Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jbmr.4173","article-title":"A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice","volume":"36","author":"Palmieri","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41467-018-04047-5","article-title":"Oxidation-specific epitopes restrain bone formation","volume":"9","author":"Ambrogini","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M701341200","article-title":"Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts","volume":"282","author":"Huang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.080513","article-title":"Hyperlipidemia impairs osteoanabolic effects of PTH","volume":"23","author":"Huang","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.541","article-title":"Adverse effects of hyperlipidemia on bone regeneration and strength","volume":"27","author":"Pirih","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcb.24648","article-title":"Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts","volume":"115","author":"Li","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00223-013-9772-0","article-title":"The anabolic effect of teriparatide is undermined by low levels of high-density lipoprotein cholesterol","volume":"94","author":"Jeon","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Domazetovic, V., Marcucci, G., Falsetti, I., Bilia, A.R., Vincenzini, M.T., Brandi, M.L., and Iantomasi, T. (2020). Blueberry Juice Antioxidants Protect Osteogenic Activity against Oxidative Stress and Improve Long-Term Activation of the Mineralization Process in Human Osteoblast-Like SaOS-2 Cells: Involvement of SIRT1. Antioxidants, 9.","DOI":"10.3390\/antiox9020125"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"153107","DOI":"10.1016\/j.phymed.2019.153107","article-title":"Effect of gomisin A on osteoblast differentiation in high glucose-mediated oxidative stress","volume":"66","author":"Takanche","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bone.2009.01.003","article-title":"Glutaredoxin 5 regulates osteoblast apoptosis by protecting against oxidative stress","volume":"44","author":"Linares","year":"2009","journal-title":"Bone"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bone.2008.12.011","article-title":"Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia","volume":"44","author":"Hamada","year":"2009","journal-title":"Bone"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1463-1326.2007.00782.x","article-title":"Regulation of pancreatic beta-cell function by the forkhead protein FoxO1","volume":"9","author":"Buteau","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.1109083","article-title":"Functional interaction between beta-catenin and FOXO in oxidative stress signaling","volume":"308","author":"Essers","year":"2005","journal-title":"Science"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"27298","DOI":"10.1074\/jbc.M702811200","article-title":"Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor-to forkhead box O-mediated transcription","volume":"282","author":"Almeida","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"45485","DOI":"10.1074\/jbc.M309069200","article-title":"Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways","volume":"278","author":"Dowell","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"19881","DOI":"10.1074\/jbc.M600320200","article-title":"FOXO1 represses peroxisome proliferator-activated receptor-gamma 1 and -gamma 2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity","volume":"281","author":"Armoni","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2009.12.009","article-title":"FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice","volume":"3","author":"Ambrogini","year":"2010","journal-title":"Cell Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1083\/jcb.200410041","article-title":"Phosphorylation of p66Shc and forkhead proteins mediates Abeta toxicity","volume":"169","author":"Smith","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","article-title":"I\u03baB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a","volume":"117","author":"Hu","year":"2004","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41574-020-0335-y","article-title":"The role of cellular senescence in ageing and endocrine disease","volume":"16","author":"Khosla","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e154888","DOI":"10.1172\/JCI154888","article-title":"Cellular senescence and the skeleton: Pathophysiology and therapeutic implications","volume":"132","author":"Khosla","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e135236","DOI":"10.1172\/jci.insight.135236","article-title":"Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes","volume":"5","author":"Eckhardt","year":"2020","journal-title":"JCI Insight"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: The health, aging, and body composition study","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.25.10.1749","article-title":"Older women with diabetes have a higher risk of falls: A prospective study","volume":"25","author":"Schwartz","year":"2002","journal-title":"Diabetes Care"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","article-title":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00223-016-0229-0","article-title":"Obesity, Type 2 Diabetes and Bone in Adults","volume":"100","author":"Walsh","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2353\/ajpath.2009.080627","article-title":"A physical mechanism for coupling bone resorption and formation in adult human bone","volume":"174","author":"Andersen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11914-022-00740-z","article-title":"Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature","volume":"20","author":"Tanios","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: Mechanisms of injury and protective factors","volume":"17","author":"King","year":"2013","journal-title":"Cell Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e3718","DOI":"10.1210\/clinem\/dgaa388","article-title":"Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus","volume":"105","author":"Samakkarnthai","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","article-title":"Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease","volume":"174","author":"Shanbhogue","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jbmr.3057","article-title":"Type 2 Diabetes Mellitus Is Associated with Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study","volume":"32","author":"Nilsson","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00223-022-01007-6","article-title":"Increased Cortical Porosity, Reduced Cortical Thickness, and Reduced Trabecular and Cortical Microhardness of the Superolateral Femoral Neck Confer the Increased Hip Fracture Risk in Individuals with Type 2 Diabetes","volume":"111","author":"Cirovic","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1463-1326.2012.01583.x","article-title":"Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes","volume":"14","author":"Johnston","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: The MrOSstudy","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2017.12.011","article-title":"The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus","volume":"109","author":"Sarodnik","year":"2018","journal-title":"Maturitas"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc06-2537","article-title":"Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: The health, aging, and body composition study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS)","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.2658","article-title":"Neuromuscular dysfunction in type 2 diabetes: Underlying mechanisms and effect of resistance training","volume":"32","author":"Orlando","year":"2016","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Zoppini, G., Galletti, A., Targher, G., Brangani, C., Pichiri, I., Negri, C., Stoico, V., Cacciatori, V., and Bonora, E. (2013). Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082733"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1507\/endocrj.EJ12-0269","article-title":"The association of serum 25-hydroxyvitamin D and vertebral fractures in patients with type 2 diabetes","volume":"60","author":"Kim","year":"2013","journal-title":"Endocr. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: An emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00508-019-1462-0","article-title":"Diagnose und Management der Osteoporosebei Diabetes mellitus (Update 2019): GemeinsameLeitlinie der \u00d6sterreichischen Gesellschaft f\u00fcrKnochen- und Mineralstoffwechsel und der \u00d6sterreichischen Diabetes Gesellschaft [Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2019): Common guideline of the Austrian Society for Bone and Mineral Research and the Austrian Diabetes Society]","volume":"131","author":"Muschitz","year":"2019","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.24.7.1198","article-title":"Diabetes and risk of fracture: The Blue Mountains Eye study","volume":"24","author":"Ivers","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bone.2007.02.021","article-title":"Biphasic fracture risk in diabetes: A population-based study","volume":"40","author":"Leslie","year":"2007","journal-title":"Bone"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture risk in type 2 diabetes: Update of a population-based study","volume":"23","author":"Melton","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: The Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.21994","article-title":"PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells","volume":"106","author":"Shockley","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-015-3660-2","article-title":"The effect of thiazolidinediones on bone mineral density and bone turnover: Systematic review and meta-analysis","volume":"58","author":"Billington","year":"2015","journal-title":"Diabetologia"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.numecd.2022.10.004","article-title":"Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes","volume":"33","author":"Cairoli","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2008-0926","article-title":"National Osteoporosis Foundation Guide Committee. A revised clinician\u2019s guide to the prevention and treatment of osteoporosis","volume":"93","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.metabol.2012.05.010","article-title":"Hip geometry in diabetic women: Implications for fracture risk","volume":"61","author":"Garg","year":"2012","journal-title":"Metabolism"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.metabol.2013.05.004","article-title":"Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: Insight into the BMD and bone fragility paradox","volume":"62","author":"Hamilton","year":"2013","journal-title":"Metabolism"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/acr.20602","article-title":"Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls","volume":"64","author":"Pritchard","year":"2012","journal-title":"Arthritis Care Res."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/4\/928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:33Z","timestamp":1760123733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/4\/928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":148,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["antiox12040928"],"URL":"https:\/\/doi.org\/10.3390\/antiox12040928","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}